Published 5 Feb 2026

2nd Advances in Translational Drug Development 2026

Events

Key topics

Join us on September 22nd, 2026 at BioCity, Nottingham as we bring together leaders from academia, biotech, and pharma as we explore how an integrated discovery‑to‑development mindset, linking translational science with modality‑aware developability, can accelerate the journey from early hypotheses to clinical development. Discover the tools, technologies, and approaches that help turn innovative concepts into viable therapeutic candidates, with a spotlight on emerging modalities. Key topics will include:

Bridging discovery to development
Translational biology and biomarkers
New developments in TPDs and oligonucleotides
Designing for developability across modalities
Platform thinking and tech transfer

Badge Registration Form

2nd Advances in Translational Drug Development 2026

Name

This field is for validation purposes and should be left unchanged.

Name(Required)

First Last

Email(Required)

Company(Required)

Job Title

Country(Required)

Dietary restrictions, allergies, or accessibility requirements

Please note the deadline to register for catering is September 16th. Late registrants should contact the organisers directly with dietary requirements.

Who Should Attend

This event is designed for academic and industry professionals working across the drug discovery pipeline from early target validation through to clinical translation, with a focus on new modalities and challenging drug targets.

You should attend if you are:

A scientific leader or program head advancing small molecule, oligonucleotide, bRo5, or targeted protein degradation projects
A translational scientist or assay developer
A CSO, VP of Discovery, or Head of R&D shaping strategies for complex and emerging therapeutic modalities
A medicinal chemist, pharmacologist, or bioengineer tackling the undruggable or optimizing beyond-rule-of-5 candidates
Academic group leaders and research directors

Join us to explore how science, technology, and interdisciplinary collaboration are reshaping the future of drug development.